Certified by Founder Lodge
Cadenza Bio
United States - Oklahoma City
START UP
1 Disclosed Funding Rounds $2,440,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cadenza Bio, Inc. was founded in 2022 to accelerate and support the development of a series of novel, non-steroidal, highly selective compounds targeting Estrogen Receptor β (ERβ). Our patent
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 18 ,2023 | Seed | $2,440,000 |
Cortado Ventures
Plains Ventures
Oklahoma Life Science Fund
Boyd Street Ventures
Illinois Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
